Omega Therapeutics (OMGA) delivered earnings and revenue surprises of -3.45% and 109.63%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock ...
Moderna (MRNA) is up more than +3% after reporting Q3 Covid-19 vaccine revenue of $1.8 billion, which is stronger than the consensus of $1.2 billion. Lyft (LYFT) is up more than +29% after reporting ...
Zacks.com on MSN9h
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study DataAs the third-quarter earnings season ends this week, the focus in the biotech sector is mostly on pipeline and key regulatory ...
Insights into Mairs and Power (Trades, Portfolio)'s Latest 13F Filing and Portfolio Changes. Warning! GuruFocus has detected ...
Third Quarter 2024Robust TPV growth, up 41% YoY and 8% QoQ, driven by strong performance across various verticals and countriesRecord gross profit reaching $78M in the quarter, with net take rate stab ...
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced results for the third quarter and nine months ended September 30, 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback